DocSym
β
Searchsearch
Search
(A22.0) Cutaneous anthrax
More details coming soon
706 in individuals diagnosis cutaneous anthrax confirmed
Diagnosis cutaneous anthrax is diagnosed Women are 5.38% more likely than Men
334
Men receive the diagnosis cutaneous anthrax
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
372
Women receive the diagnosis cutaneous anthrax
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease cutaneous anthrax - Men aged 30-34 and Women aged 10-14
In Men diagnosis is most often set at age 30-34
Less common in men the disease occurs at Age 0-29, 35-95+Less common in women the disease occurs at Age 0-9, 15-95+
In Women diagnosis is most often set at age 10-14
Disease Features cutaneous anthrax
Absence or low individual and public risk
Cutaneous anthrax - what does this mean
Cutaneous anthrax is caused by the bacteria bacillus anthracis and is usually contracted through contact with infected animals or contaminated animal products. it is characterized by the formation of a lesion on the skin which can become filled with fluid. it is treatable with antibiotics, but can be fatal if left untreated.
What happens during the disease - cutaneous anthrax
Cutaneous anthrax is a bacterial infection caused by bacillus anthracis, which is found in soil and animal products. it usually enters the body through a cut or abrasion on the skin and is spread by contact with contaminated items. the bacteria release toxins that cause necrotizing lesions on the skin, leading to swelling, pain, and black lesions that eventually form a characteristic black eschar. if left untreated, the infection can spread to the lymph nodes and bloodstream, leading to systemic symptoms and death.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Review patient history
- Physical examination of the affected area
- Gram staining of the lesion
- Bacterial culture of the lesion
- Blood tests to detect antibodies against B. anthracis
- Polymerase chain reaction (PCR) to detect B. anthracis DNA
- Imaging tests such as X-ray or CT scan
Treatment and Medical Assistance
Main goal of the treatment: To reduce the symptoms and prevent the spread of infection.
- Administer antibiotics such as penicillin, doxycycline, or ciprofloxacin.
- Clean and cover the affected area.
- Provide supportive care, such as fluids and rest.
- Monitor vital signs.
- Provide wound care.
- Monitor for any signs of infection.
- Educate the patient about the disease.
- Provide emotional support.
- Provide information about preventative measures.
15 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Cutaneous anthrax - Prevention
Cutaneous anthrax can be prevented by avoiding contact with infected animals or animal products, wearing protective clothing when handling animals or animal products, and promptly seeking medical attention if contact is made with an infected animal or product. vaccination is also available for those at high risk of exposure.